Intrinsiqs

Is IRadimed Corporation overvalued?

IRadimed Corporation (IRMD) looks fairly valued — trading about 4% above its fair value.

Fairly valued
Current price $85.35 Fair value $82.03
Price
$85.35
Fair value
$82.03
Current P/E
42.9
Normal P/E
41.2
Market cap
$1.09B
Dividend yield
1.5%
Return on equity
23.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IRMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.